Target intelligence / Profile preview

Ingested toxins and drugs in the gastrointestinal lumen

Molecular classification
Xenobiotics, Small molecules, Toxins, Chemicals
01

Overview

This target refers to a diverse array of exogenous substances, including pharmaceutical agents, environmental toxins, and hazardous chemicals, that are present within the gastrointestinal lumen following oral ingestion. In clinical toxicology, these substances are the focus of decontamination efforts aimed at preventing systemic absorption and subsequent toxicity. The most common pharmacological intervention is the administration of activated charcoal, which acts as a non-specific adsorbent by trapping molecules within its porous structure (StatPearls, NBK482294). This process is highly dependent on the timing of administration and the chemical properties of the ingested substance, such as its molecular size and polarity. While not a biological macromolecule like a receptor or enzyme, these substances represent the physical target for agents designed to mitigate the effects of poisoning (Wikipedia, Activated charcoal (medication)). Effective management of these substances is a cornerstone of emergency medicine for treating drug overdoses and accidental poisonings (NIH, MedlinePlus). However, certain substances like alcohols, hydrocarbons, and corrosive agents are not effectively targeted by standard adsorbents and require specific alternative treatments.

Other names
Ingested poisonsGastrointestinal xenobioticsToxicants in the gastrointestinal tractExogenous chemicals in the gutBroad range of ingested drugs, toxins, and poisonous chemicals
02

Mechanism of action

The primary mechanism involves physical adsorption, where the ingested substances bind to the large surface area of an adsorbent like activated charcoal through van der Waals forces and hydrogen bonding, thereby preventing their absorption across the gastrointestinal epithelium into the systemic circulation (StatPearls, NBK482294).

03

Biological functions

None (Exogenous substances)
04

Disease associations

PoisoningDrug overdoseChemical toxicityAcute intoxication
05

Safety considerations

Aspiration pneumonitisGastrointestinal perforationBowel obstructionReduced efficacy of co-administered oral medicationsElectrolyte imbalances
06

Interacting drugs

Activated charcoal

4 more in the full profile.

07

Biomarkers

Serum drug concentrationUrinary toxicology screenBlood pH and electrolyte levelsAnion gapOsmolar gap

Beyond the preview

Go deeper on Ingested toxins and drugs in the gastrointestinal lumen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ingested toxins and drugs in the gastrointestinal lumen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call